Latest Stem Cells news
FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host After Allo-HSCT
posted December 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Itacitinib Helps Prevent Graft Versus Host Disease in Stem Cell Transplant Recipients
posted December 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH: Auto-HCT Not Beneficial for Mantle Cell Lymphoma With Undetectable Residual Disease
posted December 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Overall Survival Improving for Umbilical Cord Blood Transplant
posted October 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Response to Autologous HSCT Durable for Patients With Systemic Sclerosis 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 
MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms 
Stem Cell Treatment Feasible for Aniridia-Related Keratopathy Related Articles
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma 
Definition of Functional High-Risk Multiple Myeloma Updated in Era of Combo Therapy 
A-Fib Occurs Frequently in Patients With Multiple Myeloma Undergoing Stem Cell Transplant Monthly Specialist Briefings
Stay Connected
